Catalent Inc (NYSE:CTLT)
$ 55.61 0 (0%) Market Cap: 10.06 Bil Enterprise Value: 14.88 Bil PE Ratio: 0 PB Ratio: 2.79 GF Score: 81/100

Catalent Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 03:00PM GMT
Release Date Price: $84.17 (-0.18%)
Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

Hi, everyone, and thank you for joining us today at day 3 of Morgan Stanley's Global Healthcare conference. I'm Ricky Goldwasser. I'm Morgan Stanley's healthcare services analyst.

And before we get started, please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. The webcast is not for members of the press. And if you are a member of the press, please disconnect and reach out separately. And for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com. If you have any questions, please reach out to your Morgan Stanley sales representative.

And with that, I'm very pleased to introduce Catalent's CEO, John Chiminski; and CFO, Wetteny Joseph, here. They're here with us this morning.

John and Whitney, obviously, 2020 was a very meaningful year for Catalent. You've been, I think, the top performer stock in our coverage, with an exception for 1 stock,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot